Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 80

1.

Structural and Functional Studies of the Membrane-Binding Domain of NADPH-Cytochrome P450 Oxidoreductase.

Xia C, Shen AL, Duangkaew P, Kotewong R, Rongnoparut P, Feix J, Kim JP.

Biochemistry. 2019 May 14;58(19):2408-2418. doi: 10.1021/acs.biochem.9b00130. Epub 2019 May 1.

PMID:
31009206
2.

Conformational Changes and Membrane Interaction of the Bacterial Phospholipase, ExoU: Characterization by Site-Directed Spin Labeling.

Feix JB, Kohn S, Tessmer MH, Anderson DM, Frank DW.

Cell Biochem Biophys. 2019 Mar;77(1):79-87. doi: 10.1007/s12013-018-0851-8. Epub 2018 Jul 25.

PMID:
30047043
3.

Identification of a ubiquitin-binding interface using Rosetta and DEER.

Tessmer MH, Anderson DM, Pickrum AM, Riegert MO, Moretti R, Meiler J, Feix JB, Frank DW.

Proc Natl Acad Sci U S A. 2018 Jan 16;115(3):525-530. doi: 10.1073/pnas.1716861115. Epub 2018 Jan 2.

4.

A Budding-Defective M2 Mutant Exhibits Reduced Membrane Interaction, Insensitivity to Cholesterol, and Perturbed Interdomain Coupling.

Herneisen AL, Sahu ID, McCarrick RM, Feix JB, Lorigan GA, Howard KP.

Biochemistry. 2017 Nov 7;56(44):5955-5963. doi: 10.1021/acs.biochem.7b00924.

5.

Structure and Dynamics of Type III Secretion Effector Protein ExoU As determined by SDSL-EPR Spectroscopy in Conjunction with De Novo Protein Folding.

Fischer AW, Anderson DM, Tessmer MH, Frank DW, Feix JB, Meiler J.

ACS Omega. 2017 Jun 30;2(6):2977-2984. doi: 10.1021/acsomega.7b00349. Epub 2017 Jun 27.

6.

Cooperative Substrate-Cofactor Interactions and Membrane Localization of the Bacterial Phospholipase A2 (PLA2) Enzyme, ExoU.

Tessmer MH, Anderson DM, Buchaklian A, Frank DW, Feix JB.

J Biol Chem. 2017 Feb 24;292(8):3411-3419. doi: 10.1074/jbc.M116.760074. Epub 2017 Jan 9.

7.

Cholesterol-Dependent Conformational Exchange of the C-Terminal Domain of the Influenza A M2 Protein.

Kim SS, Upshur MA, Saotome K, Sahu ID, McCarrick RM, Feix JB, Lorigan GA, Howard KP.

Biochemistry. 2015 Dec 15;54(49):7157-67. doi: 10.1021/acs.biochem.5b01065. Epub 2015 Nov 30.

8.

Cross Kingdom Activators of Five Classes of Bacterial Effectors.

Anderson DM, Feix JB, Frank DW.

PLoS Pathog. 2015 Jul 23;11(7):e1004944. doi: 10.1371/journal.ppat.1004944. eCollection 2015 Jul. Review. No abstract available.

9.

Intra-operative hydroxyethyl starch is not associated with post-craniotomy hemorrhage.

Feix JA, Peery CA, Gan TJ, Warner DS, James ML, Zomorodi A, McDonagh DL.

Springerplus. 2015 Jul 16;4:350. doi: 10.1186/s40064-015-1126-0. eCollection 2015.

10.

Ubiquitin activates patatin-like phospholipases from multiple bacterial species.

Anderson DM, Sato H, Dirck AT, Feix JB, Frank DW.

J Bacteriol. 2015 Feb;197(3):529-41. doi: 10.1128/JB.02402-14. Epub 2014 Nov 17.

11.

Disruption of LptA oligomerization and affinity of the LptA-LptC interaction.

Schultz KM, Feix JB, Klug CS.

Protein Sci. 2013 Nov;22(11):1639-45. doi: 10.1002/pro.2369.

12.

Identification of the major ubiquitin-binding domain of the Pseudomonas aeruginosa ExoU A2 phospholipase.

Anderson DM, Feix JB, Monroe AL, Peterson FC, Volkman BF, Haas AL, Frank DW.

J Biol Chem. 2013 Sep 13;288(37):26741-52. doi: 10.1074/jbc.M113.478529. Epub 2013 Aug 1.

13.

Changes to the financial responsibility for juvenile court ordered psychiatric evaluations reduce inpatient services utilization: an interrupted time series study.

Epstein RA, Feix J, Arbogast PG, Beckjord SH, Bobo WV.

BMC Health Serv Res. 2012 May 30;12:136. doi: 10.1186/1472-6963-12-136.

14.

Ubiquitin and ubiquitin-modified proteins activate the Pseudomonas aeruginosa T3SS cytotoxin, ExoU.

Anderson DM, Schmalzer KM, Sato H, Casey M, Terhune SS, Haas AL, Feix JB, Frank DW.

Mol Microbiol. 2011 Dec;82(6):1454-67. doi: 10.1111/j.1365-2958.2011.07904.x. Epub 2011 Nov 21.

15.

Membrane fluidity profiles as deduced by saturation-recovery EPR measurements of spin-lattice relaxation times of spin labels.

Mainali L, Feix JB, Hyde JS, Subczynski WK.

J Magn Reson. 2011 Oct;212(2):418-25. doi: 10.1016/j.jmr.2011.07.022. Epub 2011 Aug 4.

16.

Induced conformational changes in the activation of the Pseudomonas aeruginosa type III toxin, ExoU.

Benson MA, Komas SM, Schmalzer KM, Casey MS, Frank DW, Feix JB.

Biophys J. 2011 Mar 2;100(5):1335-43. doi: 10.1016/j.bpj.2011.01.056.

17.

Effects of D-Lysine Substitutions on the Activity and Selectivity of Antimicrobial Peptide CM15.

Kaminski HM, Feix JB.

Polymers (Basel). 2011;3(4):2088-2106. doi: 10.3390/polym3042088. Epub 2011 Dec 6.

18.

Decreased S-nitrosation of peptide thiols in the membrane interior.

Zhang H, Andrekopoulos C, Xu Y, Joseph J, Hogg N, Feix J, Kalyanaraman B.

Free Radic Biol Med. 2009 Oct 1;47(7):962-8. doi: 10.1016/j.freeradbiomed.2009.06.031. Epub 2009 Jun 30.

19.

Physical properties of lipid bilayers from EPR spin labeling and their influence on chemical reactions in a membrane environment.

Subczynski WK, Widomska J, Feix JB.

Free Radic Biol Med. 2009 Mar 15;46(6):707-18. doi: 10.1016/j.freeradbiomed.2008.11.024. Epub 2008 Dec 11. Review.

20.

Lysine-enriched cecropin-mellitin antimicrobial peptides with enhanced selectivity.

Sato H, Feix JB.

Antimicrob Agents Chemother. 2008 Dec;52(12):4463-5. doi: 10.1128/AAC.00810-08. Epub 2008 Oct 13.

21.

Methods and applications of site-directed spin labeling EPR spectroscopy.

Klug CS, Feix JB.

Methods Cell Biol. 2008;84:617-58.

PMID:
17964945
22.

Intoxication and settled insanity: a finding of not guilty by reason of insanity.

Feix J, Wolber G.

J Am Acad Psychiatry Law. 2007;35(2):172-82.

PMID:
17592162
23.

Membrane insertion and bilayer perturbation by antimicrobial peptide CM15.

Pistolesi S, Pogni R, Feix JB.

Biophys J. 2007 Sep 1;93(5):1651-60. Epub 2007 May 11.

24.

Identification of superoxide dismutase as a cofactor for the pseudomonas type III toxin, ExoU.

Sato H, Feix JB, Frank DW.

Biochemistry. 2006 Aug 29;45(34):10368-75.

PMID:
16922513
25.

Osmoprotection of bacterial cells from toxicity caused by antimicrobial hybrid peptide CM15.

Sato H, Feix JB.

Biochemistry. 2006 Aug 22;45(33):9997-10007.

PMID:
16906758
26.
27.

Characterization of phospholipase activity of the Pseudomonas aeruginosa type III cytotoxin, ExoU.

Sato H, Feix JB, Hillard CJ, Frank DW.

J Bacteriol. 2005 Feb;187(3):1192-5.

29.

An immunodominant epitope of myelin basic protein is an amphipathic alpha-helix.

Bates IR, Feix JB, Boggs JM, Harauz G.

J Biol Chem. 2004 Feb 13;279(7):5757-64. Epub 2003 Nov 20.

30.

A validation of the test of memory malingering in a forensic psychiatric setting.

Weinborn M, Orr T, Woods SP, Conover E, Feix J.

J Clin Exp Neuropsychol. 2003 Oct;25(7):979-90.

PMID:
13680444
31.

The mechanism of action of the Pseudomonas aeruginosa-encoded type III cytotoxin, ExoU.

Sato H, Frank DW, Hillard CJ, Feix JB, Pankhaniya RR, Moriyama K, Finck-Barbançon V, Buchaklian A, Lei M, Long RM, Wiener-Kronish J, Sawa T.

EMBO J. 2003 Jun 16;22(12):2959-69.

32.

Membrane-anchoring and charge effects in the interaction of myelin basic protein with lipid bilayers studied by site-directed spin labeling.

Bates IR, Boggs JM, Feix JB, Harauz G.

J Biol Chem. 2003 Aug 1;278(31):29041-7. Epub 2003 May 14.

33.

Transmembrane nitration of hydrophobic tyrosyl peptides. Localization, characterization, mechanism of nitration, and biological implications.

Zhang H, Bhargava K, Keszler A, Feix J, Hogg N, Joseph J, Kalyanaraman B.

J Biol Chem. 2003 Mar 14;278(11):8969-78. Epub 2003 Jan 7.

34.

Deamidation, but not truncation, decreases the urea stability of a lens structural protein, betaB1-crystallin.

Kim YH, Kapfer DM, Boekhorst J, Lubsen NH, Bächinger HP, Shearer TR, David LL, Feix JB, Lampi KJ.

Biochemistry. 2002 Nov 26;41(47):14076-84.

PMID:
12437365
35.

Site-directed mutagenesis studies of human serum albumin define tryptophan at amino acid position 214 as the principal site for nitrosation.

Harohalli K, Petersen CE, Ha CE, Feix JB, Bhagavan NV.

J Biomed Sci. 2002 Jan-Feb;9(1):47-58.

PMID:
11810025
36.
37.

Expression of a human serum albumin fragment (consisting of subdomains IA, IB, and IIA) and a study of its properties.

Park DS, Petersen CE, Ha C, Harohalli K, Feix JB, Bhagavan NV.

IUBMB Life. 1999 Aug;48(2):169-74.

38.

A dynamic model for bilirubin binding to human serum albumin.

Petersen CE, Ha CE, Harohalli K, Feix JB, Bhagavan NV.

J Biol Chem. 2000 Jul 14;275(28):20985-95.

39.

Structural investigations of a new familial dysalbuminemic hyperthyroxinemia genotype.

Petersen CE, Ha CE, Harohalli K, Park DS, Feix JB, Isozaki O, Bhagavan NV.

Clin Chem. 1999 Aug;45(8 Pt 1):1248-54.

41.
44.

Ligand-specific opening of a gated-porin channel in the outer membrane of living bacteria.

Jiang X, Payne MA, Cao Z, Foster SB, Feix JB, Newton SM, Klebba PE.

Science. 1997 May 23;276(5316):1261-4.

45.

Dimerization of transcobalamin II receptor. Requirement of a structurally ordered lipid bilayer.

Bose S, Feix J, Seetharam S, Seetharam B.

J Biol Chem. 1996 May 17;271(20):11718-25.

46.

Denaturant unfolding of the ferric enterobactin receptor and ligand-induced stabilization studied by site-directed spin labeling.

Klug CS, Su W, Liu J, Klebba PE, Feix JB.

Biochemistry. 1995 Oct 31;34(43):14230-6.

PMID:
7578022
47.

Spin-labeling study of the oxidative damage to low-density lipoprotein.

Singh RJ, Feix JB, Mchaourab HS, Hogg N, Kalyanaraman B.

Arch Biochem Biophys. 1995 Jun 20;320(1):155-61.

PMID:
7793976
48.

A site-directed spin-labeling study of ligand-induced conformational change in the ferric enterobactin receptor, FepA.

Liu J, Rutz JM, Klebba PE, Feix JB.

Biochemistry. 1994 Nov 15;33(45):13274-83.

PMID:
7947735
49.

Enhancement of merocyanine 540 uptake and photodynamic cell killing by salicylates.

Feix JB, Anderson MS, Kalyanaraman B.

Cancer Res. 1994 Jul 1;54(13):3474-8.

50.

Supplemental Content

Support Center